{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T17:42:07Z","timestamp":1778521327872,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:00:00Z","timestamp":1760745600000},"content-version":"am","delay-in-days":321,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100001009","name":"Bristol-Myers Squibb Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["1K01AG070329"],"award-info":[{"award-number":["1K01AG070329"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jamda.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jamda.2024.105294","type":"journal-article","created":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T04:44:02Z","timestamp":1728017042000},"page":"105294","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparative Effectiveness and Safety of Direct Oral Anticoagulants vs Warfarin among Nursing Home Residents with Atrial Fibrillation: A Retrospective Cohort Study"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9134-6370","authenticated-orcid":false,"given":"Hemalkumar B.","family":"Mehta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuya","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huijun","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Caleb","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2024.105294_bib1","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jamda.2012.03.007","article-title":"Prevalence of atrial fibrillation in US nursing homes: results from the National Nursing Home Survey, 1985-2004","volume":"13","author":"Reardon","year":"2012","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2024.105294_bib2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/CIRCULATIONAHA.105.595140","article-title":"Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence","volume":"114","author":"Miyasaka","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jamda.2024.105294_bib3","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.amjcard.2013.05.063","article-title":"Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population","volume":"112","author":"Colilla","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jamda.2024.105294_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/nrcardio.2017.172","article-title":"Milestone 2: warfarin: from rat poison to clinical use","author":"Lim","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jamda.2024.105294_bib5","article-title":"Changes in anticoagulant utilization among United States nursing home residents with atrial fibrillation from 2011 to 2016","volume":"8","author":"Alcusky","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jamda.2024.105294_bib6","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jamda.2024.105294_bib7","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jamda.2024.105294_bib8","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jamda.2024.105294_bib9","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jamda.2024.105294_bib10","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.122.008951","article-title":"Comparative effectiveness and safety of direct oral anticoagulants versus warfarin among adults with cancer and atrial fibrillation","volume":"15","author":"Mehta","year":"2022","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jamda.2024.105294_bib11","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/CIRCULATIONAHA.122.060687","article-title":"Comparative effectiveness and safety of direct oral anticoagulants and warfarin in patients with atrial fibrillation and chronic liver disease: a nationwide cohort study","volume":"147","author":"Lawal","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jamda.2024.105294_bib12","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1007\/s11606-020-05777-3","article-title":"Comparative safety and effectiveness of direct-acting oral anticoagulants versus warfarin: a national cohort study of nursing home residents","volume":"35","author":"Alcusky","year":"2020","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.jamda.2024.105294_bib13","author":"Medicare"},{"key":"10.1016\/j.jamda.2024.105294_bib14","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2147\/CLEP.S230677","article-title":"Combining inpatient and outpatient data for diagnosis of non-valvular atrial fibrillation using electronic health records: a validation study","volume":"12","author":"Reges","year":"2020","journal-title":"Clin Epidemiol"},{"issue":"suppl 1","key":"10.1016\/j.jamda.2024.105294_bib15","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/pds.2312","article-title":"A\u00a0systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative data","volume":"21 suppl 1","author":"Andrade","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jamda.2024.105294_bib16","author":"Sentinel"},{"key":"10.1016\/j.jamda.2024.105294_bib18","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jamda.2020.10.001","article-title":"Geographic variation in anticoagulant use and resident, nursing home, and county characteristics associated with treatment among US nursing home residents","volume":"22","author":"Alcusky","year":"2021","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2024.105294_bib19","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jamda.2020.04.029","article-title":"Time trends in opioid use by dementia severity in long-term care nursing home residents","volume":"22","author":"Mehta","year":"2021","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2024.105294_bib20","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.jamda.2024.105294_bib21","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A\u00a0novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.jamda.2024.105294_bib22","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/sim.6607","article-title":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies","volume":"34","author":"Austin","year":"2015","journal-title":"Stat Med"},{"key":"10.1016\/j.jamda.2024.105294_bib23","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1161\/CIRCULATIONAHA.114.012061","article-title":"Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation","volume":"131","author":"Graham","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jamda.2024.105294_bib24","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.jamda.2019.11.022","article-title":"Safety and effectiveness of direct oral anticoagulants vs warfarin in people with atrial fibrillation and dementia","volume":"21","author":"Fanning","year":"2020","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2024.105294_bib25","article-title":"Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation","volume":"3","author":"Bruins Slot","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jamda.2024.105294_bib26","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jamda.2024.01.011","article-title":"Predictors and outcomes of oral anticoagulant deprescribing in geriatric inpatients with atrial fibrillation: a retrospective multicenter cohort study","volume":"25","author":"Brunetti","year":"2024","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2024.105294_bib27","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.jamda.2019.01.131","article-title":"Identifying factors that predict the prescription of non-vitamin K antagonist oral anticoagulants in older individuals with atrial fibrillation","volume":"20","author":"Shurrab","year":"2019","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2024.105294_bib28","author":"American College of Cardiology"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861024007163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861024007163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T02:54:28Z","timestamp":1732676068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525861024007163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1525861024007163"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2024.105294","relation":{},"ISSN":["1525-8610"],"issn-type":[{"value":"1525-8610","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative Effectiveness and Safety of Direct Oral Anticoagulants vs Warfarin among Nursing Home Residents with Atrial Fibrillation: A Retrospective Cohort Study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Medical Directors Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jamda.2024.105294","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Post-Acute and Long-Term Care Medical Association.","name":"copyright","label":"Copyright"}],"article-number":"105294"}}